{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:08:55Z","timestamp":1783721335940,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Foundation of Shandong","award":["ZR202112010298"],"award-info":[{"award-number":["ZR202112010298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15519-5","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:04:24Z","timestamp":1768208664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive pan-cancer analysis and experimental verification of the roles of SCP2 in colon adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"2","key":"15519_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jamaoncol.2024.5381","volume":"11","author":"KAB Goddard","year":"2025","unstructured":"Goddard KAB, Feuer EJ, Mandelblatt JS, Meza R, Holford TR, Jeon J, et al. Estimation of cancer deaths averted from Prevention, Screening, and treatment Efforts, 1975\u20132020. JAMA Oncol. 2025;11(2):162\u20137.","journal-title":"JAMA Oncol"},{"issue":"1","key":"15519_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"15519_CR3","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1158\/2159-8290.CD-25-0375","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Joshu CE, Curtis SD, Douville C, Burk VA, Ru M, et al. Detection of cancers three years prior to diagnosis using plasma Cell-Free DNA. Cancer Discov. 2025;15(9):1794\u2013802.","journal-title":"Cancer Discov"},{"issue":"1","key":"15519_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li Y, Liu F, Cai Q, Deng L, Ouyang Q, Zhang XH, et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct Target Ther. 2025;10(1):57.","journal-title":"Signal Transduct Target Ther"},{"key":"15519_CR5","doi-asserted-by":"publisher","first-page":"101229","DOI":"10.1016\/j.drup.2025.101229","volume":"81","author":"JR Wei","year":"2025","unstructured":"Wei JR, Lu MY, Wei TH, Fleishman JS, Yu H, Chen XL, et al. Overcoming cancer therapy resistance: from drug innovation to therapeutics. Drug Resist Updat. 2025;81:101229.","journal-title":"Drug Resist Updat"},{"issue":"7","key":"15519_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/cac2.70008","volume":"45","author":"X Cen","year":"2025","unstructured":"Cen X, Lan Y, Zou J, Chen R, Hu C, Tong Y, et al. Pan-cancer analysis shapes the Understanding of cancer biology and medicine. Cancer Commun (Lond). 2025;45(7):728\u201346.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"15519_CR7","doi-asserted-by":"publisher","first-page":"e0149728","DOI":"10.1371\/journal.pone.0149728","volume":"11","author":"NC Li","year":"2016","unstructured":"Li NC, Fan J, Papadopoulos V. Sterol carrier Protein-2, a nonspecific Lipid-Transfer Protein, in intracellular cholesterol trafficking in testicular Leydig cells. PLoS ONE. 2016;11(2):e0149728.","journal-title":"PLoS ONE"},{"issue":"6","key":"15519_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbalip.2007.04.005","volume":"1771","author":"F Schroeder","year":"2007","unstructured":"Schroeder F, Atshaves BP, McIntosh AL, Gallegos AM, Storey SM, Parr RD, et al. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochim Biophys Acta. 2007;1771(6):700\u201318.","journal-title":"Biochim Biophys Acta"},{"key":"15519_CR9","doi-asserted-by":"publisher","first-page":"155180","DOI":"10.1016\/j.metabol.2022.155180","volume":"131","author":"C Xu","year":"2022","unstructured":"Xu C, Li H, Tang CK. Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications. Metabolism. 2022;131:155180.","journal-title":"Metabolism"},{"issue":"2","key":"15519_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.gendis.2021.12.007","volume":"10","author":"C Xu","year":"2023","unstructured":"Xu C, Li H, Tang CK. Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis. Genes Dis. 2023;10(2):457\u201367.","journal-title":"Genes Dis"},{"issue":"20","key":"15519_CR11","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1111\/jcmm.16930","volume":"25","author":"J Zou","year":"2021","unstructured":"Zou J, Pei X, Xing D, Wu X, Chen S. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. J Cell Mol Med. 2021;25(20):9826\u201336.","journal-title":"J Cell Mol Med"},{"key":"15519_CR12","doi-asserted-by":"crossref","unstructured":"Ahmed SBM, Radwan N, Amer S, Saheb Sharif-Askari N, Mahdami A, Samara KA, et al. Assessing the link between diabetic metabolic dysregulation and breast cancer progression. Int J Mol Sci. 2023;24(14):11816.","DOI":"10.3390\/ijms241411816"},{"key":"15519_CR13","doi-asserted-by":"publisher","first-page":"822315","DOI":"10.3389\/fcell.2021.822315","volume":"9","author":"J Yao","year":"2021","unstructured":"Yao J, Zhang Y, Li M, Sun Z, Liu T, Zhao M, et al. Single-Cell RNA-Seq reveals the promoting role of ferroptosis tendency during lung adenocarcinoma EMT progression. Front Cell Dev Biol. 2021;9:822315.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"15519_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.32604\/or.2023.028051","volume":"31","author":"W Bao","year":"2023","unstructured":"Bao W, Han Q, Guan X, Wang Z, Gu M. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma. Oncol Res. 2023;31(2):181\u201392.","journal-title":"Oncol Res"},{"issue":"1","key":"15519_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13046-019-1411-9","volume":"38","author":"X Ding","year":"2019","unstructured":"Ding X, Fan K, Hu J, Zang Z, Zhang S, Zhang Y, et al. SCP2-mediated cholesterol membrane trafficking promotes the growth of pituitary adenomas via Hedgehog signaling activation. J Exp Clin Cancer Res. 2019;38(1):404.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"15519_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180\u201391.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"15519_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41420-023-01522-x","volume":"9","author":"T Dai","year":"2023","unstructured":"Dai T, Xue X, Huang J, Yang Z, Xu P, Wang M, et al. SCP2 mediates the transport of lipid hydroperoxides to mitochondria in chondrocyte ferroptosis. Cell Death Discov. 2023;9(1):234.","journal-title":"Cell Death Discov"},{"issue":"1A","key":"15519_CR18","first-page":"A68","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwinska P, Wiznerowicz M. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68\u201377.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"6509","key":"15519_CR19","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GT Consortium","year":"2020","unstructured":"Consortium GT. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318\u201330.","journal-title":"Science"},{"issue":"4","key":"15519_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"15519_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA Pan-Cancer clinical data resource to drive High-Quality survival outcome analytics. Cell. 2018;173(2):400\u201316. e411.","journal-title":"Cell"},{"issue":"5","key":"15519_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"key":"15519_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"D1","key":"15519_CR24","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"15519_CR25","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"Suppl 4","key":"15519_CR26","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"5","key":"15519_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"D1","key":"15519_CR28","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"15519_CR29","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"issue":"3","key":"15519_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165\u201376.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"15519_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10565-025-10025-7","volume":"41","author":"C Ma","year":"2025","unstructured":"Ma C, Hu H, Liu H, Zhong C, Wu B, Lv C, et al. Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy. Cell Biol Toxicol. 2025;41(1):75.","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"15519_CR32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/neuonc\/noad233","volume":"26","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu B, Xu C, Ji C, Yin A, Liu Y, et al. Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR. Neuro Oncol. 2024;26(4):684\u2013700.","journal-title":"Neuro Oncol"},{"issue":"6","key":"15519_CR33","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.7150\/jca.63609","volume":"13","author":"X Guo","year":"2022","unstructured":"Guo X, Zhou S, Yang Z, Li ZA, Hu W, Dai L, et al. Cholesterol metabolism and its implication in glioblastoma therapy. J Cancer. 2022;13(6):1745\u201357.","journal-title":"J Cancer"},{"issue":"7","key":"15519_CR34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4161\/auto.28912","volume":"10","author":"R Liu","year":"2014","unstructured":"Liu R, Li J, Zhang T, Zou L, Chen Y, Wang K, et al. Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy. 2014;10(7):1241\u201355.","journal-title":"Autophagy"},{"issue":"1","key":"15519_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40246-022-00408-w","volume":"16","author":"M Galano","year":"2022","unstructured":"Galano M, Ezzat S, Papadopoulos V. SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects. Hum Genomics. 2022;16(1):32.","journal-title":"Hum Genomics"},{"key":"15519_CR36","doi-asserted-by":"publisher","first-page":"1270793","DOI":"10.3389\/fneur.2023.1270793","volume":"14","author":"H Tang","year":"2023","unstructured":"Tang H, Luo Y, Tang Z, Tang J, Fang J. Case report: episodic psychosis caused by a novel SCP2 splicing mutation. Front Neurol. 2023;14:1270793.","journal-title":"Front Neurol"},{"issue":"1","key":"15519_CR37","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1038\/s41467-025-61157-7","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Yamaguchi K, Rodgers B, Goehrig D, Vindrieux D, Lahaye X, et al. DNA methylation protects cancer cells against senescence. Nat Commun. 2025;16(1):5901.","journal-title":"Nat Commun"},{"issue":"1","key":"15519_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13148-025-01884-2","volume":"17","author":"A Lavoro","year":"2025","unstructured":"Lavoro A, Ricci D, Gattuso G, Longo F, Spoto G, Vitale ACV, et al. Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective. Clin Epigenetics. 2025;17(1):76.","journal-title":"Clin Epigenetics"},{"key":"15519_CR39","doi-asserted-by":"publisher","first-page":"564796","DOI":"10.3389\/fonc.2020.564796","volume":"10","author":"H Feng","year":"2020","unstructured":"Feng H, Shen W. ACAA1 is a predictive factor of survival and is correlated with T cell infiltration in Non-Small cell lung cancer. Front Oncol. 2020;10:564796.","journal-title":"Front Oncol"},{"issue":"10","key":"15519_CR40","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1158\/0008-5472.CAN-22-2143","volume":"83","author":"WT Peng","year":"2023","unstructured":"Peng WT, Jin X, Xu XE, Yang YS, Ma D, Shao ZM, et al. Inhibition of ACAA1 restrains proliferation and potentiates the response to CDK4\/6 inhibitors in Triple-Negative breast cancer. Cancer Res. 2023;83(10):1711\u201324.","journal-title":"Cancer Res"},{"issue":"11","key":"15519_CR41","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41416-023-02448-y","volume":"129","author":"M Shen","year":"2023","unstructured":"Shen M, Liu S, Toland A, Hsu EC, Hartono AB, Alabi BR, et al. ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype. Br J Cancer. 2023;129(11):1818\u201328.","journal-title":"Br J Cancer"},{"issue":"1","key":"15519_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41421-022-00515-x","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Yang X, Wu J, Ye S, Gong J, Cheng WM, et al. Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes beta-catenin palmitoylation to drive colorectal cancer progression. Cell Discov. 2023;9(1):26.","journal-title":"Cell Discov"},{"issue":"1","key":"15519_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41392-025-02221-y","volume":"10","author":"C Wei","year":"2025","unstructured":"Wei C, Liao K, Chen HJ, Xiao ZX, Meng Q, Liu ZK, et al. Nuclear mitochondrial acetyl-CoA acetyltransferase 1 orchestrates natural killer cell-dependent antitumor immunity in colorectal cancer. Signal Transduct Target Ther. 2025;10(1):138.","journal-title":"Signal Transduct Target Ther"},{"key":"15519_CR44","doi-asserted-by":"publisher","first-page":"1395192","DOI":"10.3389\/fonc.2024.1395192","volume":"14","author":"T Sun","year":"2024","unstructured":"Sun T, Xiao X. Targeting ACAT1 in cancer: from threat to treatment. Front Oncol. 2024;14:1395192.","journal-title":"Front Oncol"},{"issue":"1","key":"15519_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12885-020-07717-0","volume":"21","author":"S Okamura","year":"2021","unstructured":"Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, et al. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive MicroRNAs in bladder cancer. BMC Cancer. 2021;21(1):48.","journal-title":"BMC Cancer"},{"issue":"13","key":"15519_CR46","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1158\/0008-5472.CAN-20-3944","volume":"81","author":"APY Ma","year":"2021","unstructured":"Ma APY, Yeung CLS, Tey SK, Mao X, Wong SWK, Ng TH, et al. Suppression of ACADM-Mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant CAV1\/SREBP1 signaling. Cancer Res. 2021;81(13):3679\u201392.","journal-title":"Cancer Res"},{"key":"15519_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13148-018-0458-3","volume":"10","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Lu H, Zhang D, Li M, Sun X, Wan L, et al. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clin Epigenetics. 2018;10:30.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"15519_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pathol.2021.06.119","volume":"54","author":"Y Sekine","year":"2022","unstructured":"Sekine Y, Yamamoto K, Kurata M, Honda A, Onishi I, Kinowaki Y, et al. HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma. Pathology. 2022;54(3):286\u201393.","journal-title":"Pathology"},{"issue":"12","key":"15519_CR49","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P. Metabolic reprogramming, sensing, and cancer therapy. Cell Rep. 2024;43(12):115064.","journal-title":"Cell Rep"},{"issue":"1","key":"15519_CR50","doi-asserted-by":"publisher","first-page":"189051","DOI":"10.1016\/j.bbcan.2023.189051","volume":"1879","author":"G Pascual","year":"2024","unstructured":"Pascual G, Majem B, Benitah SA. Targeting lipid metabolism in cancer metastasis. Biochim Biophys Acta Rev Cancer. 2024;1879(1):189051.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"15519_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","volume":"23","author":"Y Wu","year":"2024","unstructured":"Wu Y, Pu X, Wang X, Xu M. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy. Lipids Health Dis. 2024;23(1):35.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"15519_CR52","doi-asserted-by":"publisher","first-page":"189416","DOI":"10.1016\/j.bbcan.2025.189416","volume":"1880","author":"D Zhao","year":"2025","unstructured":"Zhao D, Wu L, Li Y. Targeting lipid metabolism to enhance cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2025;1880(5):189416.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"15519_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34(3):355\u201377.","journal-title":"Cell Metab"},{"issue":"2","key":"15519_CR54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2(2):132\u201341.","journal-title":"Nat Metab"},{"issue":"8","key":"15519_CR55","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/s41401-025-01531-9","volume":"46","author":"CL Dai","year":"2025","unstructured":"Dai CL, Qiu ZY, Wang AQ, Yan S, Zhang LJ, Luan X. Targeting cholesterol metabolism: a promising therapy strategy for cancer. Acta Pharmacol Sin. 2025;46(8):2093\u2013104.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"15519_CR56","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00018-025-05617-9","volume":"82","author":"A Mordzinska-Rak","year":"2025","unstructured":"Mordzinska-Rak A, Verdeil G, Hamon Y, Blaszczak E, Trombik T. Dysregulation of cholesterol homeostasis in cancer pathogenesis. Cell Mol Life Sci. 2025;82(1):168.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"15519_CR57","first-page":"27","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27.","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"15519_CR58","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25(12):910\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"15519_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41571-025-01003-3","volume":"22","author":"E Boxer","year":"2025","unstructured":"Boxer E, Feigin N, Tschernichovsky R, Darnell NG, Greenwald AR, Hoefflin R, et al. Emerging clinical applications of single-cell RNA sequencing in oncology. Nat Rev Clin Oncol. 2025;22(5):315\u201326.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"15519_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden M, Spranger S. Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat Rev Immunol. 2025;25(5):353\u201369.","journal-title":"Nat Rev Immunol"},{"key":"15519_CR61","doi-asserted-by":"publisher","first-page":"1472772","DOI":"10.3389\/fimmu.2024.1472772","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang L, Zhang Z, Wu P, Zhang Y, Chen X. Advances in targeting tumor microenvironment for immunotherapy. Front Immunol. 2024;15:1472772.","journal-title":"Front Immunol"},{"issue":"1","key":"15519_CR62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","volume":"14","author":"W Yu","year":"2021","unstructured":"Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, et al. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol. 2021;14(1):187.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"15519_CR63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00262-025-04133-w","volume":"74","author":"M Klopotowska","year":"2025","unstructured":"Klopotowska M, Baranowska I, Hajduk S, Jurga A, Lesniowska N, Lazniewski M, et al. GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis. Cancer Immunol Immunother. 2025;74(9):280.","journal-title":"Cancer Immunol Immunother"},{"key":"15519_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbrc.2021.08.082","volume":"576","author":"L Han","year":"2021","unstructured":"Han L, Bai L, Qu C, Dai E, Liu J, Kang R, et al. PPARG-mediated ferroptosis in dendritic cells limits antitumor immunity. Biochem Biophys Res Commun. 2021;576:33\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7939","key":"15519_CR65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612(7939):338\u201346.","journal-title":"Nature"},{"issue":"11","key":"15519_CR66","doi-asserted-by":"publisher","first-page":"109235","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35(11):109235.","journal-title":"Cell Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15519-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15519-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15519-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:03:10Z","timestamp":1770724990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15519-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15519"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15519-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}